AEHR stock forecast, quote, news & analysis
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits... Show more
Aehr Test Systems (AEHR) Stock Analysis: AI and Silicon Photonics Orders Fuel a High-Growth Trajectory
Key Takeaways
- Aehr Test Systems (AEHR) has moved approximately +5.4% over the last 30 days, reflecting consolidation after a period of extreme volatility and massive year-to-date gains exceeding 400%.
- The company secured a record $41 million follow-on production order from its lead hyperscale AI customer in April 2026, with second-half bookings surpassing $92 million.
- A new major silicon photonics customer win and follow-on orders for wafer-level burn-in systems underscore Aehr's expanding role in AI data center infrastructure and optical interconnects.
- Despite strong order momentum, the company remains unprofitable on a trailing basis, with TTM revenue of $45.26 million and a net loss of $11.42 million, making execution on its growing backlog a critical watchpoint.
- Analyst consensus rates AEHR a "Buy," though the average 12-month price target of $63.67 sits well below current trading levels, reflecting the stock's premium valuation.
Current Market Snapshot
Aehr Test Systems (AEHR) has been one of the most explosive small-cap semiconductor stocks of 2026, delivering year-to-date gains north of 400% as of mid-June. The stock's 52-week range tells a dramatic story: from a low of $10.89 in June 2025 to an all-time high of $126.62 touched in June 2026. Over the last 30 days, however, AEHR has entered a period of heightened volatility and consolidation, with the share price moving from approximately $99.50 in mid-May to around $104.83 by mid-June — a modest gain of roughly 5.4%. Daily swings of 10% to 15% in either direction have become routine, reflecting the stock's beta of 3.18 and the intense speculative interest surrounding its AI-driven growth narrative. Trading volumes have consistently exceeded 2 million shares per day, signaling robust institutional and retail engagement.
Aehr Test Systems (AEHR) Business Overview and Competitive Position
Aehr Test Systems, headquartered in Fremont, California, designs, manufactures, and sells advanced test and burn-in equipment for the semiconductor industry. Founded in 1977, the company has evolved into a critical enabler of quality and reliability testing for next-generation chips. Its flagship FOX-XP and FOX-NP systems perform full-wafer contact and singulated die/module test and burn-in for a wide range of devices — including silicon carbide power semiconductors, 2D and 3D sensors, memory chips, processors, microcontrollers, and increasingly, silicon photonics and AI ASICs. The FOX-CP system offers a lower-cost single-wafer solution for logic, memory, and photonic devices. Complementary products like the WaferPak contactor and DiePak carrier complete the ecosystem. Aehr's competitive moat lies in its proprietary automation and full-wafer parallel testing capability, which reduces cost and accelerates time-to-market for chip manufacturers. With only 136 employees, the company operates a lean, high-leverage business model that scales with semiconductor capital expenditure cycles — particularly those driven by AI, data center, and optical interconnect demand.
Recent Developments Driving AEHR
The last 30 days have been eventful for Aehr Test Systems. In late May, the company presented at the William Blair 46th Annual Growth Stock Conference, where management highlighted the expanding total addressable market for wafer-level and package-level burn-in, especially as semiconductor complexity and reliability requirements intensify across AI, memory, and silicon photonics applications. The presentation triggered a sharp 21% single-day rally on June 2. Earlier in the quarter, Aehr disclosed a follow-on production order from a major silicon photonics customer for a fully automated FOX-XP wafer-level burn-in system configured to test nine wafers in parallel — a development that sent shares up 9% in a single session. These announcements build on the record $41 million production order received in April from the company's lead hyperscale AI customer, which pushed second-half fiscal 2026 bookings past $92 million. On the analyst front, Craig-Hallum upgraded AEHR from Hold to Buy in early April with a $68 price target, while William Blair upgraded the stock to Outperform in March. However, the stock has also experienced sharp selloffs — including a 15.6% drop on June 5 — reflecting profit-taking and the inherent volatility of a high-beta, high-momentum name. The company also entered into a $60 million at-the-market equity offering agreement in April, providing a capital buffer to fund manufacturing expansion.
Trending AI Robots
For traders seeking to navigate volatile stocks like Aehr Test Systems with data-driven precision, Tickeron's Trending AI Robots page offers a curated view of top-performing AI-powered trading bots. Tickeron hosts hundreds of AI robots that actively trade thousands of tickers across diverse strategies, timeframes, and performance metrics. The Trending AI Robots section highlights only those bots demonstrating the strongest recent results and highest relevance to current market conditions — helping users cut through the noise. Whether focused on momentum, swing trading, or pattern recognition, these bots provide real-time signals and actionable insights. Exploring this page can help traders identify AI-driven strategies aligned with their own risk tolerance and market outlook.
2026 Outlook and What Investors Should Watch
Looking ahead, Aehr Test Systems sits at a pivotal juncture. The company's record backlog — driven by hyperscale AI processor demand and emerging silicon photonics opportunities — provides strong revenue visibility into fiscal 2027. The next earnings report, expected in July 2026, will be critical for assessing whether Aehr can convert its order momentum into improving bottom-line results. Key metrics to watch include gross margin trends, operating expense discipline, and cash flow generation. The silicon photonics market, which enables high-speed optical interconnects inside data centers, represents a potentially transformative growth vector that could diversify Aehr's customer concentration beyond its lead hyperscale partner. Macroeconomic factors — including interest rate policy, semiconductor capital expenditure cycles, and potential trade restrictions — also warrant close attention. With the stock trading at a significant premium to analyst price targets and carrying a price-to-sales ratio above 70, execution risk remains elevated. Investors should monitor booking announcements, manufacturing capacity updates, and any shifts in AI infrastructure spending patterns as the primary signals for Aehr's trajectory through the remainder of 2026.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AEHR sees MACD Histogram just turned negative
AEHR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on June 23, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 35 instances where the indicator turned negative. In of the 35 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on June 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
AEHR moved below its 50-day moving average on June 26, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 251 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 48, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (25.707) is normal, around the industry mean (12.514). P/E Ratio (19.449) is within average values for comparable stocks, (117.123). AEHR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.237). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (75.758) is also within normal values, averaging (128.191).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment